Immuneering Corp(IMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRX Immuneering Corp

盘前交易 10-09 06:58:03 EDT

6.50

+0.39

+6.38%

盘前6.54

+0.04+0.62%

06:55 EDT

最高6.54	最低6.13	成交量229.95万
今开6.24	昨收6.11	日振幅6.78%
总市值4.11亿	流通市值3.54亿	总股本6,324万
成交额1,461万	换手率4.23%	流通股本5,441万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":6.5,"timestamp":1759953600000,"preClose":6.11,"halted":0,"volume":2299476,"hourTrading":{"tag":"盘前","latestPrice":6.54,"preClose":6.5,"latestTime":"06:55 EDT","volume":1467,"amount":9600.709616999999,"timestamp":1760007302033},"delay":0,"floatShares":54411779,"shares":63238699,"eps":-1.876712,"marketStatus":"盘前交易","change":0.39,"latestTime":"10-09 06:58:03 EDT","open":6.24,"high":6.54,"low":6.1259,"amount":14611117.467722401,"amplitude":0.067774,"askPrice":6.54,"askSize":95,"bidPrice":6.53,"bidSize":335,"shortable":3,"etf":0,"ttmEps":-1.876712,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760016600000},"marketStatusCode":1,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":6.5,"preHourTrading":{"tag":"盘前","latestPrice":6.54,"preClose":6.5,"latestTime":"06:55 EDT","volume":1467,"amount":9600.709616999999,"timestamp":1760007302033},"postHourTrading":{"tag":"盘后","latestPrice":6.64,"preClose":6.5,"latestTime":"19:59 EDT","volume":46237,"amount":306546.594,"timestamp":1759967963168},"volumeRatio":0.8089574148641684,"impliedVol":0.2211,"impliedVolPercentile":0.2},"requestUrl":"/m/hq/s/IMRX","defaultTab":"news","newsList":[{"id":"2572559182","title":"Immuneering Corporation盘中异动 早盘急速下跌5.14%报6.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572559182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572559182?lang=zh_cn&edition=full","pubTime":"2025-10-01 22:07","pubTimestamp":1759327649,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日22时07分，Immuneering Corporation股票出现波动，股价大幅下挫5.14%。截至发稿，该股报6.64美元/股，成交量99.6637万股，换手率1.58%，振幅5.57%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为1.80%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001220729a45036e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001220729a45036e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"1167720395","title":"Immuneering Corp将于2025年9月29日周一讨论Atebimetinib联合Mgnp治疗一线胰腺癌患者2a期临床试验的最新总体生存期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1167720395","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167720395?lang=zh_cn&edition=full","pubTime":"2025-09-27 04:01","pubTimestamp":1758916899,"startTime":"0","endTime":"0","summary":"Immuneering Corp计划于2025年9月29日周一就其最近公布的Atebimetinib联合Mgnp治疗一线胰腺癌患者2a期临床试验的总体生存期数据进行讨论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IMRX","BK4563"],"gpt_icon":0},{"id":"1164778643","title":"Immuneering Corp宣布完成1.75亿美元A类普通股承销公开发行定价，同时向Sanofi进行2500万美元私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1164778643","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164778643?lang=zh_cn&edition=full","pubTime":"2025-09-25 12:09","pubTimestamp":1758773367,"startTime":"0","endTime":"0","summary":"Immuneering Corp宣布完成1.75亿美元A类普通股承销公开发行定价，同时向Sanofi进行2500万美元私募配售","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","IMRX","BK4539"],"gpt_icon":0},{"id":"1193887538","title":"Immuneering Corp宣布拟议承销公开发行A类普通股和预付费认股权证，同时向Sanofi进行A类和B类普通股私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1193887538","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193887538?lang=zh_cn&edition=full","pubTime":"2025-09-25 04:05","pubTimestamp":1758744315,"startTime":"0","endTime":"0","summary":"Immuneering Corp宣布，公司计划进行A类普通股和预付费认股权证的承销公开发行，同时向Sanofi进行A类普通股和B类普通股的私募配售。\n这一融资计划包括两个部分：首先是面向公众投资者的承销发行，涉及A类普通股和预付费认股权证；其次是与法国制药巨头Sanofi同期进行的私募配售交易，涉及A类和B类普通股。\n该公司此次融资举措旨在为其业务发展和研发项目提供资金支持。具体的发行规模、定价和时间安排等详细信息尚待进一步公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IMRX","BK4139","BK4563"],"gpt_icon":0},{"id":"1157786888","title":"Immuneering Corp宣布一线胰腺癌患者接受Atebimetinib + Mgnp治疗后9个月总生存率达86%的卓越成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1157786888","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157786888?lang=zh_cn&edition=full","pubTime":"2025-09-25 04:02","pubTimestamp":1758744144,"startTime":"0","endTime":"0","summary":"Immuneering Corp宣布一线胰腺癌患者接受Atebimetinib + Mgnp治疗后9个月总生存率达86%的卓越成果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4563","BK4539","BK4139"],"gpt_icon":0},{"id":"2566993612","title":"Immuneering Corporation盘中异动 股价大涨10.71%报7.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566993612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566993612?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:32","pubTimestamp":1757511128,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时32分，Immuneering Corporation股票出现异动，股价大幅上涨10.71%。截至发稿，该股报7.81美元/股，成交量22.5808万股，换手率0.54%，振幅6.38%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.48%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910213208a71bf764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910213208a71bf764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","IMRX","BK4139"],"gpt_icon":0},{"id":"1141181627","title":"Immuneering Corp将于9月25日公布Atebimetinib + Mgnp治疗一线胰腺癌患者2a期临床试验的最新总生存期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1141181627","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141181627?lang=zh_cn&edition=full","pubTime":"2025-09-10 19:02","pubTimestamp":1757502131,"startTime":"0","endTime":"0","summary":"Immuneering Corp将于9月25日公布Atebimetinib + Mgnp治疗一线胰腺癌患者2a期临床试验的最新总生存期数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","IMRX","BK4539"],"gpt_icon":0},{"id":"1142181606","title":"Immuneering宣布完成2500万美元私人配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1142181606","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142181606?lang=zh_cn&edition=full","pubTime":"2025-08-27 04:10","pubTimestamp":1756239034,"startTime":"0","endTime":"0","summary":"马萨诸塞州剑桥，2025年8月26日——专注于延长癌症患者生命的临床阶段肿瘤公司Immuneering Corp今日宣布完成此前公布的私人配售。此次私人配售面向顶级机构投资者和合格投资者，扣除费用和开支前的总收益约为2500万美元。Leerink Partners担任Immuneering此次私人配售的财务顾问。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","IMRX","BK4139"],"gpt_icon":0},{"id":"1108193013","title":"Immuneering Corp宣布与礼来签署临床供应协议，评估Atebimetinib联合Olomorasib的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1108193013","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108193013?lang=zh_cn&edition=full","pubTime":"2025-08-25 20:04","pubTimestamp":1756123444,"startTime":"0","endTime":"0","summary":"Immuneering Corp宣布与礼来签署临床供应协议，双方将联合评估Atebimetinib与Olomorasib的组合疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU2491050154.USD","LU2461242641.AUD","LU0256863902.USD","SG9999014880.SGD","LU0096364046.USD","SG9999018857.SGD","LU1868836757.USD","LU0094547139.USD","LU0320765059.SGD","LU2552382132.HKD","LU1069344957.HKD","LU0061475181.USD","LU1983299246.USD","IE0004445239.USD","LU2089984988.USD","LU0820561909.HKD","LU0466842654.USD","SG9999014898.SGD","LU2746668974.SGD","LU2456880835.USD","SGXZ81514606.USD","BK4533","BK4007","LU2491050071.SGD","LU2236285917.USD","BK4539","LU0689472784.USD","LU2361044865.SGD","LU1623119135.USD","LU0823416689.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU0106261372.USD","LU0354030438.USD","LU1712237335.SGD","GB00BDT5M118.USD","LU0006306889.USD","LU1061106388.HKD","LU0432979614.USD","LU0058720904.USD","LU2471134796.USD","SG9999014914.USD","IE00BK4W5M84.HKD","LU1023059063.AUD","LU0109391861.USD","LU0786609619.USD","LU2023250504.SGD","LU0640476718.USD","LU1291159041.SGD","LU0256863811.USD","LU2468319806.SGD","LU0114720955.EUR","BK4581","LU2237443895.HKD","LU0471298694.HKD","LU1814569148.SGD","LU0889565916.HKD","LU2357305700.SGD","SG9999015945.SGD","LU2491049909.HKD","LU0943347566.SGD","LU2360106947.USD","LU1720051017.SGD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1093756168.USD","LU0385154629.USD","LU0672654240.SGD","BK4563","LU0203202063.USD","IE00BJJMRZ35.SGD","LU1127390331.HKD","IE00BK4W5L77.USD","LU2471134523.USD","LU0198837287.USD","SG9999015986.USD","LU2106854487.HKD","LU0122379950.USD","SG9999018865.SGD","LU0316494557.USD","IE00BFTCPJ56.SGD","LU2237438978.USD","IE00BJLML261.HKD","LU1064131342.USD","SGXZ51526630.SGD","SGXZ57979304.SGD","SG9999014906.USD","SG9999015952.SGD","LU0882574139.USD","LU1057294990.SGD","LU2750360997.AUD","SGXZ99366536.SGD","LU1093756325.SGD","LU2108987350.USD","LU0320765992.SGD","LU1868836914.USD","LU2063271972.USD","IE00B2B36J28.USD","LU1035775433.USD","LU0820561818.USD","LU2602419157.SGD","LU1804176565.USD","LU1868836591.USD","LU0266013472.USD","LLY","LU2361045086.USD","LU0234572021.USD","LU0823434740.USD","LU2237443465.HKD","BK4585","LU1988902786.USD","LU0882574055.USD","BK4599","SGXZ31699556.SGD","LU0708995401.HKD","LU0354030511.USD","LU2237443622.USD","LU1720051108.HKD","LU2237443978.SGD","LU0456855351.SGD","LU2462157665.USD","BK4534","LU1974910355.USD","LU0417517546.SGD","LU2237443549.SGD","LU1868837300.USD","LU0823434583.USD","LU1989771016.USD","SG9999001176.SGD","SG9999015978.USD","SG9999013999.USD","BK4588","LU2552382215.SGD","LU2361044949.HKD","LU1868837136.USD","LU0097036916.USD","LU0289739699.SGD","LU0079474960.USD","BK4516","LU2471134952.CNY","LU1366192091.USD","LU1917777945.USD","LU1232071149.USD","LU1551013342.USD","SG9999017495.SGD","LU1551013425.SGD","LU0471298777.SGD","LU2112291526.USD","LU0238689110.USD","LU2417539215.USD","SG9999001176.USD","LU0323591593.USD","LU2552382058.USD","LU2750360641.GBP","LU1280957306.USD","IMRX","LU2471134879.HKD","LU0109394709.USD","LU0203201768.USD","IE0002141913.USD","LU2264538146.SGD","LU2211815571.USD","IE0009355771.USD","LU1267930730.SGD","BK4139","LU2265009873.SGD","LU2746668461.USD","LU1548497426.USD"],"gpt_icon":0},{"id":"2558665081","title":"Immuneering Corporation盘中异动 早盘股价大涨5.23%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665081?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:43","pubTimestamp":1754919822,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时43分，Immuneering Corporation股票出现异动，股价快速拉升5.23%。截至发稿，该股报3.42美元/股，成交量4.0251万股，换手率0.11%，振幅5.23%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.17%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121434394dcc40c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121434394dcc40c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","BK4539","IMRX"],"gpt_icon":0},{"id":"2558798645","title":"Immuneering Corporation盘中异动 下午盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558798645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558798645?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:17","pubTimestamp":1754673465,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时17分，Immuneering Corporation股票出现波动，股价快速下跌5.13%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Alector, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为631.45%、169.95%、102.32%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为75.81%、73.00%、46.49%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011745973c3f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011745973c3f84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2556585319","title":"Immuneering Corporation盘中异动 快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556585319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556585319?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:53","pubTimestamp":1753991587,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时53分，Immuneering Corporation股票出现波动，股价快速下跌5.10%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Celularity Inc C/Wts 16/07/2026 涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为11407.74%、5165.18%、4956.03%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为297.60%、97.88%、97.44%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801035307a46e1cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801035307a46e1cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRX","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2555294640","title":"Immuneering Corporation盘中异动 股价大跌5.43%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555294640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555294640?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:20","pubTimestamp":1753903225,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时20分，Immuneering Corporation股票出现波动，股价急速下跌5.43%。截至发稿，该股报3.48美元/股，成交量13.6328万股，换手率0.38%，振幅6.52%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.07%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032025a46c0663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032025a46c0663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IMRX","BK4139","BK4563"],"gpt_icon":0},{"id":"2555105028","title":"Immuneering Corporation盘中异动 大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555105028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555105028?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:00","pubTimestamp":1753801226,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时00分，Immuneering Corporation股票出现异动，股价大幅下跌5.23%。截至发稿，该股报3.71美元/股，成交量10.6753万股，换手率0.30%，振幅6.14%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.26%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729230027a6c81253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729230027a6c81253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","IMRX","BK4139"],"gpt_icon":0},{"id":"2554677248","title":"Immuneering Corporation盘中异动 急速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554677248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554677248?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:39","pubTimestamp":1753709944,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时39分，Immuneering Corporation股票出现异动，股价急速跳水5.16%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为229.33%、96.09%、85.96%，振幅较大的相关个股有Celcuity Inc.、Aim Immunotech Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为36.31%、35.83%、20.41%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821390594bf71df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821390594bf71df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRX","BK4139","BK4563","BK4539"],"gpt_icon":0},{"id":"2551844881","title":"Immuneering Corporation盘中异动 早盘股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551844881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551844881?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:40","pubTimestamp":1752500437,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时40分，Immuneering Corporation股票出现异动，股价快速跳水5.88%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Dare Bioscience, Inc.、Promis Neurosciences Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1644.63%、414.58%、172.94%，振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Promis Neurosciences Inc.，振幅分别为91.45%、78.63%、56.35%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214037a6a8f3ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214037a6a8f3ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IMRX","BK4139","BK4563"],"gpt_icon":0},{"id":"2550624184","title":"Immuneering Corporation盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550624184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550624184?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:25","pubTimestamp":1752161152,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时25分，Immuneering Corporation股票出现波动，股价快速跳水5.17%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Q32 Bio Inc.、Cognition Therapeutics, Inc.、Pelthos Therapeutics Inc.涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Klotho Neurosciences, Inc.较为活跃，换手率分别为350.75%、211.73%、148.06%，振幅较大的相关个股有Q32 Bio Inc.、Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.，振幅分别为90.07%、73.27%、55.38%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710232553a6a1e9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710232553a6a1e9ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRX","BK4139","BK4563","BK4539"],"gpt_icon":0},{"id":"2550696608","title":"Immuneering Corporation7月9日成交额为868.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550696608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550696608?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:47","pubTimestamp":1752115637,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Immuneering Corporation成交额为868.91万美元，成交额较昨日增加185.40%，当日成交量为198.99万股。Immuneering Corporation于2025年7月9日涨11.25%，报4.45美元，该股过去5个交易日涨29.36%，年初至今涨102.27%，过去60日涨258.87%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-09|868.91万|185.40%|198.99万|#|2025-07-08|304.46万|-62.72%|75.23万|#|2025-07-07|816.72万|161.26%|207.57万|#|2025-07-03|312.60万|22.47%|90.85万|#|2025-07-02|255.24万|-10.01%|70.81万|Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710104720a441862b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710104720a441862b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2550505499","title":"Immuneering Corporation7月8日成交额为304.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550505499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550505499?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:46","pubTimestamp":1752029167,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Immuneering Corporation成交额为304.46万美元，成交额较昨日减少62.72%，当日成交量为75.23万股。Immuneering Corporation于2025年7月8日跌1.23%，报4.0美元，该股过去5个交易日涨18.69%，年初至今涨81.82%，过去60日涨210.08%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|304.46万|-62.72%|75.23万|#|2025-07-07|816.72万|161.26%|207.57万|#|2025-07-03|312.60万|22.47%|90.85万|#|2025-07-02|255.24万|-10.01%|70.81万|#|2025-07-01|283.63万|-17.76%|82.77万|Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709104611a43f3bde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709104611a43f3bde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2549558814","title":"Immuneering Corporation盘中异动 快速拉升5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558814?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:50","pubTimestamp":1751896230,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时50分，Immuneering Corporation股票出现异动，股价急速拉升5.65%。截至发稿，该股报3.64美元/股，成交量14.9582万股，换手率0.42%，振幅5.51%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.59%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司专有的计算疾病消除技术平台使Immuneering的药物发现计划成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707215031979d1c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707215031979d1c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRX","BK4563","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuneering.com","stockEarnings":[{"period":"1week","weight":0.022},{"period":"1month","weight":0.0924},{"period":"3month","weight":0.5012},{"period":"6month","weight":4.0388},{"period":"1year","weight":1.7197},{"period":"ytd","weight":1.9545}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0756},{"period":"6month","weight":0.2606},{"period":"1year","weight":0.1744},{"period":"ytd","weight":0.1485}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuneering Corporation于2008年在特拉华州注册成立。该公司是一家临床阶段的肿瘤学公司，寻求为广泛的癌症患者群体开发和商业化通用RAS/RAF药物。该公司的目标是通过对MAPK通路的深度循环抑制来实现这种普遍的RAS/RAF活性，在保留健康细胞的同时冲击癌细胞。公司的包容性方法将公司与狭义靶向精准疗法区分开来，后者仅限于携带特定突变的肿瘤患者。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.209299},{"month":2,"riseRate":0.5,"avgChangeRate":-0.044801},{"month":3,"riseRate":0.25,"avgChangeRate":0.059789},{"month":4,"riseRate":0.25,"avgChangeRate":-0.2067},{"month":5,"riseRate":0.25,"avgChangeRate":0.005771},{"month":6,"riseRate":0.75,"avgChangeRate":0.3519},{"month":7,"riseRate":0.75,"avgChangeRate":0.027683},{"month":8,"riseRate":0.4,"avgChangeRate":0.157517},{"month":9,"riseRate":0.8,"avgChangeRate":0.592866},{"month":10,"riseRate":0.2,"avgChangeRate":-0.084236},{"month":11,"riseRate":0.25,"avgChangeRate":-0.159888},{"month":12,"riseRate":0.5,"avgChangeRate":-0.091275}],"exchange":"NASDAQ","name":"Immuneering Corp","nameEN":"Immuneering Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuneering Corp(IMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuneering Corp(IMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuneering Corp,IMRX,Immuneering Corp股票,Immuneering Corp股票老虎,Immuneering Corp股票老虎国际,Immuneering Corp行情,Immuneering Corp股票行情,Immuneering Corp股价,Immuneering Corp股市,Immuneering Corp股票价格,Immuneering Corp股票交易,Immuneering Corp股票购买,Immuneering Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuneering Corp(IMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuneering Corp(IMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}